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Abstract
Introduction.  Bipolar depression is often unrecognized
and difficult to treat because of two opposite problems:
treatment resistance and risk of manic switch. Case re-
port.  A  53-year-old female was suffering from unipolar
depressive disorder since the age of 36. During a recent
major depressive episode pervasive feelings of sadness,
lost of interest in activities, severe insomnia and highly ex-
pressed somatic anxiety dominated 7 months. After un-
successful tries with two different antidepressants of ade-
quate doses and duration, slow rate repetitive trascranial
magnetic stimulation (rTMS) was started, but  the patient
stayed at the fixed dose of antidepressant. Partial sleep
deprivation (PSD) was additionaly applied twice during
these 2 weeks with the idea to boost up, or enhance rTMS
treatment response. At the last two rTMS sessions depres-
sion obviously meliorated, but the patient also expressed
symptoms of hypomania. The therapy of rTMS was
stopped, hypomanic symptoms gradually vanished and
two weeks after the rTMS treatment the patient was
euthymic. Antidepressant was kept on. In a follow-up pe-
riod of 2 years the diagnose of bipolar affective disorder
was definitely established. Conclusion. This case report
shows that a combination of  slow rate rTMS and partial
sleep deprivation in the patient at the fixed dose of anti-
depressants, have strong synergistic effect even with po-
tential to induce hypomanic switch, that is the first de-
scription in the literature to our knowledge.
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Apstrakt
Uvod. Bipolarna depresija ÿesto se ne prepoznaje, a teškoýe u
njenom leÿenju odnose se na dva suprotna problema: terapij-
sku rezistenciju i rizik od maniÿnog preokreta. Prikaz boles-
nika. Bolesnica stara 53 godine, leÿena je od unipolarnog dep-
resivnog poremeýaja od svoje 36. godine. Tokom nedavne
epizode velike depresije tokom sedam meseci dominirala su
stalna oseýanja potišenosti, gubitak interesovanja za uobiÿajene
aktivnosti, teška nesanica i izrazita somatska anksioznost. Po-
sle dva neuspela terapijska pokušaja sa razliÿitim antidepresi-
vima primenjenim u odgovarajuýim dozama i dovoljno dugo,
zapoÿeta je terapija niskofrekventnom repetitivnom transkra-
nijalnom magnetnom stimulacijom (rTMS). Tokom rTMS te-
rapije bolesnica je nastavila da prima nepromenjenu dozu an-
tidepresiva. Parcijalna deprivacija spavanja (PSD) dodatno je
primenjena u dva navrata tokom ove dve nedelje sa idejom da
ýe potencirati ili pospešiti terapijski odgovor. Tokom posled-
nje dve rTMS sesije, simptomi depresije bili su znaÿajno sma-
njeni, ali je bolesnica ispoljavala i simptome hipomanije. Tera-
pija rTMS je prekinuta i hipomaniÿni simptomi su postepeno
prestali. U roku od dve nedelje posle rTMS terapije bolesnica
je bila eutimiÿna. Terapija antidepersivom je nastavljena. U pe-
riodu praýenja u naredne dve godine definitivno je postavljena
dijagnoza bipolarnog afektivnog poremeýaja.  Zakljuÿak.  U
ovom prikazu bolesnice, pokazalo se da istovremena primena
rTMS i deprivacije spavanja kod bolesnika sa nepromenjenom
dozom antidepresiva ima snažan sinergistiÿki efekat, ÿak sa
moguýnošýu da izazove maniÿni preokret, što je ujedno, pre-
ma našim saznanjima, prvi do sada objavljeni sluÿaj hipoma-
nije indukovane ovom kombinacijom antidepresivnih terapija.
Kljuÿne reÿi:
psihoze, maniÿno-depresione; dijagnoza,
diferencijalna; depresioni poremeýaji; antidepresivi;
spavanje, deprivacija; transkranijalna magnetna
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Introduction
Bipolar depression is a common and severe psychiatric
disorder with high risk of suicide, but after many high qual-
ity surveys and expert consensus in practical guidelines, it is
still often unrecognized and mismanaged. The main difficul-
ties in therapy of bipolar depression regard two opposite is-
sues: treatment resistance and risk of hypomanic/manic
switch.
Antidepressant-associated manic switch was reported to
be higher in bipolar type I disorder than unipolar depression 
1
or bipolar type II, and antidepressant induced hypoma-
nia/mania during the treatment of unipolar depression is con-
sidered as a sign of latent bipolar disorder 
2.
Transcranial magnetic stimulation (TMS) is relatively
novel method of non-invasive stimulation of brain cortex and
has been explored in neurology, psychiatry and neuroscince.
A number of randomized controlled trials have demon-
strated effecacy and safety of rTMS in major depression 
3–5,
but there are only a few rTMS trials in bipolar depression
where its efficacy and saftey has not yet been established.
Available data, until now, are controversial.
In most rTMS studies on major depression high fre-
quencies of stimulation ( 5 Hz) of the left dorso-lateral pre-
frontal cortex (DLPFC) and only a few trials used low fre-
quent ( 1 Hz) rTMS of the right DLPFC 
4, 5 suggesting its
efficacy and even better safety, compared to high frequence
rTMS.
Swich to hypomania/mania may occur also with thera-
peutic sleep deprivation 
6. A recently published review 
7 in-
cluding 53 rTMS randomized controlled trials in unipolar
and bipolar depression found that switching occurance is
similar as with antidepressant pharmacotherapy.
Several positron-emission tomography (PET) and sin-
gle-photon emission  computed tomography (SPECT) studies
already found changes in cerebral blood flow and glucosa
metabolism in prefrontal regions 
8, 9 after sleep deprivation,
similar to changes observed after rTMS treatment in depres-
sive patients 
10, that means possible synergistic effect of this
two antidepressant treatments.
Case report
A 53-year-old female was suffering from major depres-
sive disorder, according to the  Diagnostic and Statistic
Manuel of Mental Disorders – IV Edition, Text Revision
(DSM- IV-TR) 
11 criteria. The patient was highly educated,
employed, married, had two adult children, and no history of
other psychiatric or somatic disorder. In family history for
psychiatric disorders data were not completely reliable, be-
cause her father had a long period of alchohol abuse and ag-
gressive behavior, but denied psychiatric treatment.  First
major depressive episode was diagnosed when the patient
was 36 and after short antidepressant treatment she remitted
and had not been regularly monitored by the psychiatrist un-
til the age of 48. In the next 5-year period the patient had 3
major depressive episodes. The major depressive episode
(before rTMS treatment was used) started 7 months ago with
pervasive feelings of sadness, lost of interest in family and
activities, severe insomnia and highly expressed somatic
anxiety. During that episode the patient was treated as out-
patient.
Baseline Hamilton Depresssion Rating Scale -17 items
(HDRS-17) score was 27. Antidepressant treatment started
with sertraline (gradually titrated to the dose of 200 mg/day)
for about 8 weeks. Because of poor antidepressant response
with 25 points at HDRS-17, sertraline was tapered off and
the patients was treated with venlafaxine (up to 225 mg/day)
without significant improvement and after additional 9
weeks the patients had quite severe depressive symptoms
with 28 points at HDRS-17.
With the written informed consent we started rTMS
treatment. The institutional review board, following the
Declaration of Helsinki (1975), approved the experimental
procedures.
TMS was delivered by a Magstim Magnetic Stimulator
with a figure 8-shaped coil.
rTMS was then delivered at 110% rot test motor tresh-
old (RMT) intensity on the frontal scalp area overlying the
right dorsolateral prefrontal cortex (DLPFC), localized ac-
cording to previous reports 5 cm in front of the best spot for
inducing MEPs from the abductor policis brevis (APB) mus-
cle 
12.
The patient received 10 sessions of 1 Hz right prefrontal
rTMS at 110% of RMT intensity, over a 2-week period (5
days/week). Each daily session of rTMS consisted of 5 trains
60 stimuli (300 stimuli/daily), with inter-train pauses of 3
minutes, lasted approximately 20 min. The total number of
stimuli the patient received during a 2-week treatment was
3,000.
Twice during a 2-week period late partial sleep depri-
vation (PSD) was applied; the patient went to bed as usual,
woked-up at 01.30 h and stayed awake approximately the
next 20 h. We chose late PSD instead of total sleep depriva-
tion (TSD) because its proven efficacy similar to TSD (13)
and abbreviated procedure seemed more likely acceptable for
patients compliance. The patient was naive to sleep deprri-
nation as well as rTMS. A family member was monitored the
patient`s complience.
During the rTMS treatment the patient stayed at fixed
dose of venlafaxine (225 mg/day).
At the last two rTMS sessions depression obviously
meliorated (11 points at HDRS), but the patient also ex-
pressed symptoms of hypomania – became talkative, cheer-
ful, optimistic, self-confident, and hyperactive at times and
had a quite unrealistic plans. Young Mania Rating Scale
(YMRS) score was 13 (symptoms adequate to meet DSM-
IV-TR mild hypomania
 criteria).
rTMS was stopped after 10 sessions, as it was sched-
uled, because hypomania started at the end of treatment,
and patient was carefully monitored. One week after the
rTMS treatment the patient came to outpatient clinic with
milder hypomania symptoms, not so hyperactive anymore,
but still euphoric and at moments showed inappropriate
friendly attitude toward doctor and nurses (8 points at
YMRS). Two weeks after rTMS treatment patient wasVolumen 71, Broj 2 VOJNOSANITETSKI PREGLED Strana 209
Krstiý J, Iliý VT. Vojnosanit Pregl 2014; 71(2): 207–210.
definitely euthimic (4 points at YMRS, 8 points at HDRS-
17 ) and then was decided to keep on with antidepressant
treatment (225 mg venlafaxine/day), and be careful in
monitoring a possible bipolar affective disorder. Remission
was sustained in the next 8 months, when the patient was
admitted to the hospital with severe depressive symptoms.
Fifty mg/day of amytriptiline was added to venlafaxine 225
mg/day, without significant response. When amytriptiline
dose was increased to 75 mg/day, the patient switched to
mania, first time in her life. Antidepressants were stopped
and the treatment with mood stabilizer started (lithium car-
bonatis 900 mg/day). After a 2-year follow-up, the patient
stayed euthimic.
Discussion
This case report shows that a combination of slow rate
rTMS boosted with partial sleep deprivation has strong, pos-
sibly synergistic antidepressant effect, with the potential to
induce hypomanic switch in the patient at the fixed dose of
antidepressants.
Our patient previously did not respond to high doses of
sertraline and venlafaxine that justified the diagnose of
treatment resistant depression. During the rTMS treatment
the patient stayed at the fixed dose of medication, but it was
not likely that venlafaxine caused switch to hypomania (al-
though switch might be attributed to a long-term use of anti-
depressants, which may destabilize the illness). It is also not
likely that after 9 weeks at the fixed dose of venlafaxine
without mood improvement, venlafaxine caused manic
switch; moreover, the patient became euthimic when rTMS
was stopped, but venlafaxine was kept on, during the obser-
vation period. Thus, it is more likely that the low-frequent
rTMS and partial sleep deprivation had strong synergistic
antidepressant effect that result in hypomania in misdiag-
nosed bipolar spectrum disorder patient treated all the time
with antidepressant monotherapy.
Interestingly, during the first major depressive episode
in her life the patient was also treated with amytriptiline
monotherapy and with 125 mg/day had a significant im-
provement, without switch to hypomania/mania. Hypomanic
switch during rTMS combined with SD and followed by
manic switch that occurred in a follow-up period, after the
last major depressive episode, could be similar to reports of
new onset of bipolar disorder during rTMS in patients pre-
viosely thought to have unipolar illness 
14.
Bipolar affective disorder symptoms onset peaks in
much younger age and it happens rarely that a patient is first
time diagnosed as bipolar at the age of 53. Clinicians also
know this sometimes happens considering the fact that many
patients use to come on treatment only during depression
phase and almost never come during hypomania when their
subjective feeling is `high`, insight is poor and they often
deny being ill at all. Family members are also happy to see a
patient cheerful and active after severe suffering during de-
pression phase, and sometimes hypomania episodes are so
long and frequent that they see a patient as sick only during
depression and as `normal – that is he/she – during hypoma-
nia. Clinical experience often shows that proper diagnoses of
bipolar affective disorder have long delays, sometimes more
than 10 years 
15.
Nedjat and Folkerts 
16 reported transient hypomanic
symptoms during high frequency rTMS of the left PFC in 3
of 50 healthy volunteers.
Most of rTMS studies reporting on switch to hypoma-
nia/mania used high frequencies of stimulation. Until now, to
our knowledge, only a few studies using low frequencies of
stimulation in depression reported switch to hypoma-
nia/mania 
17–19.
Ella et al. 
17 reported two cases of manic switch during
slow (1 Hz) rTMS treatment of the right DLPFC in resistant
major depression, but the number of stimuli per session they
used (1,200 stimuli/day) was much higher than we used (300
stimuli/day), and was applied during 3 weeks (15 sessions);
in both cases switch occurred few days after the last sessions,
that was similar to our case.
One study used bilateral rTMS (high over the left
DLPFC and low over the right DLPFC) to enhance antide-
pressant outcome but a patient switched to mania on day 7 of
stimulation 
18.
Fitzgerald et al. 
19 in a double-blind, parallel design study
reported one switch to mania with stimulation of 1Hz, 100%
RMT, 300 stimuli/session (in a group stimulated with 10 Hz
was no switch).
Sakkas et al. 
20 in their study protocol used more aggres-
sive stimulation with 20Hz, 110% RMT, 1600 stimuli/ ses-
sion, two sessions/day and reported one case of hypomania
and one case of mania (one of them was in age of 55 first
time experienced manic symptoms related to rTMS, similarly
to our patient). This report definitely shows that mania-
induced potential of rTMS correlates with the intensity of
rTMS, but our protocol with less intensive stimulation also
resulted in switch to hypomania.
Conclusion
Our case report shows that a combination of rTMS and
partial sleep deprivation added to antidepressant may have
strong antidepressive synergistic effect even with potential to
induce hypomanic switch.
In the treatment of resistant depression clinicians always
should be aware of possible unrecognized bipolar disorder,
or, in other words, that bipolar depression is often a treat-
ment-resistant depression.
Further controlled studies should give more precise
safety guidelines and optimal tretment strategies in cases of
hypomania/mania induced by rTMS; even a bit flexible indi-
vidual strategies should still be the base of treatment of every
particular patient with bipolar depression.
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